Daily Dose - Sep 4th, 2025
Daily Dose |
View online
September 4, 2025
Enzene opens its first US biomanufacturing site, touts continuous manufacturing capabilities
The India-based CDMO’s 80,000 square-foot facility in Hopewell, New Jersey includes drug substance manufacturing suites, laboratories, storage, dispensing and warehousing.
Read More
Gilead breaks ground on California development center, part of $32B US investment
The new facility at its headquarters in Foster City will expand biologics capabilities and support technology transfer for next-generation therapies.
Read More
FDA grants Ori Biotech’s IRO platform advanced manufacturing designation
With the designation, developers using IRO are expected to gain earlier and more frequent engagement with the agency throughout regulatory processes.
Read More
